Krystal Biotech (KRYS) Change in Receivables: 2023-2025
Historic Change in Receivables for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to $17.9 million.
- Krystal Biotech's Change in Receivables rose 401.78% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.1 million, marking a year-over-year decrease of 63.55%. This contributed to the annual value of $62.7 million for FY2024, which is 49.16% up from last year.
- According to the latest figures from Q3 2025, Krystal Biotech's Change in Receivables is $17.9 million, which was up 119.13% from $8.2 million recorded in Q2 2025.
- In the past 5 years, Krystal Biotech's Change in Receivables ranged from a high of $56.8 million in Q2 2024 and a low of -$5.9 million during Q3 2024.
- Over the past 3 years, Krystal Biotech's median Change in Receivables value was $8.2 million (recorded in 2025), while the average stood at $14.4 million.
- As far as peak fluctuations go, Krystal Biotech's Change in Receivables crashed by 163.75% in 2024, and later soared by 401.78% in 2025.
- Over the past 3 years, Krystal Biotech's Change in Receivables (Quarterly) stood at $32.7 million in 2023, then crashed by 77.24% to $7.4 million in 2024, then skyrocketed by 401.78% to $17.9 million in 2025.
- Its last three reported values are $17.9 million in Q3 2025, $8.2 million for Q2 2025, and -$1.5 million during Q1 2025.